NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

302 hedge funds and large institutions have $7.51B invested in Neurocrine Biosciences in 2019 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 119 increasing their positions, 103 reducing their positions, and 53 closing their positions.

Holders
302
Holders Change
-23
Holders Change %
-7.08%
% of All Funds
6.57%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.17%
New
37
Increased
119
Reduced
103
Closed
53
Calls
$73.7M
Puts
$48.6M
Net Calls
+$25.1M
Net Calls Change
-$5.84M

Top Buyers

1
BG
1
Bellevue Group
Switzerland
$299M
2
Capital International Investors
2
Capital International Investors
California
$475M
3
HM
3
HealthCor Management
New York
$200M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$64.7M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$95M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$777M
2
Invesco
2
Invesco
Georgia
$108M
3
MWNA
3
Marshall Wace North America
New York
$0
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$961K
5
Marshall Wace
5
Marshall Wace
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$790M 9,352,240 +540,279 +6%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$777M 9,205,796 -1,231,257 -12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$685M 8,117,369 -38,488 -0.5%
BlackRock
4
BlackRock
New York
$478M 5,658,531 +163,195 +3%
Capital International Investors
5
Capital International Investors
California
$475M 5,630,354 +1,203,754 +27%
PA
6
Perceptive Advisors
New York
$340M 4,023,862 +265,200 +7%
BG
7
Bellevue Group
Switzerland
$299M 3,546,444 +3,526,244 +17,457%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$286M 3,381,769 -94,381 -3%
HM
9
HealthCor Management
New York
$200M 2,371,390 +855,300 +56%
State Street
10
State Street
Massachusetts
$157M 1,855,431 -162,723 -8%
O
11
OrbiMed
New York
$155M 1,833,200 – –
Franklin Resources
12
Franklin Resources
California
$139M 1,651,831 -387,307 -19%
BBA
13
Baker Bros. Advisors
New York
$119M 1,415,283 +316,613 +29%
Invesco
14
Invesco
Georgia
$108M 1,278,312 -644,606 -34%
First Trust Advisors
15
First Trust Advisors
Illinois
$108M 1,277,700 +194,643 +18%
AllianceBernstein
16
AllianceBernstein
Tennessee
$102M 1,203,404 +98,945 +9%
Point72 Asset Management
17
Point72 Asset Management
Connecticut
$95M 1,124,684 +735,992 +189%
RSCM
18
Rock Springs Capital Management
Maryland
$86.4M 1,023,000 +178,500 +21%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$82.4M 976,324 +27,195 +3%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$80.5M 952,942 -1,728 -0.2%
PAMU
21
Pictet Asset Management (UK)
United Kingdom
$80.2M 949,690 -29,518 -3%
Deutsche Bank
22
Deutsche Bank
Germany
$76.3M 904,141 -120,494 -12%
Norges Bank
23
Norges Bank
Norway
$72.3M 856,611 – –
Two Sigma Advisers
24
Two Sigma Advisers
New York
$67.5M 799,273 +42,400 +6%
Nuveen Asset Management
25
Nuveen Asset Management
Illinois
$64.7M 766,778 +766,778 New
1
2 3 4 5